Biomea Fusion to Participate at Upcoming Investor Conferences

(NASDAQ:BMEA), SAN CARLOS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in the upcoming investor conferences: Piper Sandler 37th Annual Healthcare Conference: Biomea will participate in a fireside chat at 8:00 AM […]

Village Farms Launches Promenade Brand’s First Vape in Quebec

(NASDAQ:VFF), HUNTINGDON, Quebec, Nov. 24, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (Nasdaq: VFF), together with its Quebec-based subsidiary Rose LifeScience Inc., today announced the launch of Promenade's first vape product, Matin. This introduction marks a major step forward for Quebec's regulated cannabis market, as Promenade becomes one of the first brands to join

Hollywood Racks Announces Two New Accessories for its CrossTrack Series

Los Angeles, CA, Nov. 24, 2025 (GLOBE NEWSWIRE) — Hollywood Racks, the family-owned California brand known for Simple – Strong – Secure.(TM) bike racks, is proud to announce the launch of two new accessories for its CrossTrack series bike racks: a 1-Bike Add-On Kit and an LED Light Bar. These additions further extend the versatility

Sionna Therapeutics to Participate in Upcoming December Investor Conferences

(NasdaqGM:SION), WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will participate in

Aldebaran Files PEA on Sedar+ and Announces Termination of the Option Agreement with Nuton Holdings Ltd.

(TSX-V:ALDE),(TSX-V:ALDE.V),(OTC US:ADBRF),(Other OTC:ADBRF), VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) — Aldebaran Resources Inc. (“Aldebaran” or the “Company“) (TSX-V: ALDE, OTCQX: ADBRF) is pleased to announce the filing on SEDAR+ of an updated Technical Report and Preliminary Economic Assessment (the “Altar PEA”) on the Altar copper-gold project located in San Juan Province, Argentina, prepared

Tilray Unveils Good Supply Vapes in Quebec Following the Recent Introduction of Vape Products in Quebec

(NASDAQ:TLRY),(TSX:TLRY), TORONTO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced the introduction of Good Supply vape products in Quebec as part of the launch of legal cannabis vaping

Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference

(NASDAQ:CRDF), SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a fireside chat and 1×1 investor meetings at the Piper Sandler 37th Annual Healthcare Conference, which is

Gaming and Leisure Properties, Inc. Declares Fourth Quarter 2025 Cash Dividend of $0.78 Per Share

(NASDAQ:GLPI), WYOMISSING, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI” or the “Company”), announced today that the Company's Board of Directors has declared the fourth quarter 2025 cash dividend of $0.78 per share of its common stock. The dividend is payable on December 19, 2025 to shareholders of

JPMorgan Announces Cash Distributions for the JPMorgan ETFs

(TSX:JEPI),(TSX:JEPQ), TORONTO, Nov. 24, 2025 (GLOBE NEWSWIRE) — J. P. Morgan Asset Management (JPMAM)* today announced the final November 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of record on December 1, 2025 will receive cash distributions payable on December 5, 2025. Details

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

(NASDAQ:ARVN),(NYSE:PFE), NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that multiple abstracts on vepdegestrant (ARV-471) have been accepted for presentation at the upcoming San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12,

Scroll to Top